Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carbowet is a branded generic digestive aid developed and marketed by Globus Remedies, a pharmaceutical company based in India. The formulation is designed to alleviate symptoms of gastrointestinal distress, including indigestion, flatulence, and dyspepsia. It typically combines the adsorbent properties of **activated charcoal** with the enzymatic actions of **fungal diastase** and **papain**. Activated charcoal works by binding to intestinal gas and toxins, thereby reducing bloating and abdominal distension. Fungal diastase, an amylase enzyme, facilitates the breakdown of complex carbohydrates and starch into simpler sugars, while papain, a proteolytic enzyme derived from *Carica papaya*, assists in the digestion of dietary proteins. Carbowet is available in multiple dosage forms, such as syrups and tablets, to support overall digestive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on activated charcoal + fungal diastase + papain.